Prosecution Insights
Prosecution Insights
45 pending office actions • 24 clients • 44 examiners • 32 art units • 0 of 45 (0%) have an AI response strategy ready • 51 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 45 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 45 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 27 (60%) |
| §102 only | 7 (16%) |
| §112 only | 4 (9%) |
| Double-patenting + other | 2 (4%) |
| No statute on record | 5 (11%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PIHONAK, SARAH | 2 | 60.9% | +43.4% |
| MCWILLIAMS, KELSEY LYNN | 1 | 91.3% | +5.5% |
| OLSON, ANDREA STEFFEL | 1 | 62.2% | -12.5% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 60.9% | +38.7% |
| PATWARDHAN, ABHISHEK A | 1 | 74.1% | +11.2% |
| HOWELL, THEODORE R | 1 | 66.8% | +25.4% |
| DEKARSKE, MADELINE MCGUIRE | 1 | — | — |
| YOUNG, MICAH PAUL | 1 | 55.1% | +30.1% |
| ALSOMAIRY, SARAH ABDOALATIF | 1 | 60.1% | +25.4% |
| FRONDA, CHRISTIAN L | 1 | 82.4% | +14.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19314941 | A METHOD FOR PRODUCING PLANTS WITH MINIMIZED BIOMASS BYPRODUCT AND ASSOCIATED PLANTS THEREOF | MCWILLIAMS, KELSEY LYNN | 26d |
| 18277444 | ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF | FRONDA, CHRISTIAN L | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18634406 | SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF | SULLIVAN, STEPHANIE LAUREN | 131d overdue |
| 18462235 | METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS | YOUNG, MICAH PAUL | 71d overdue |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | ALSOMAIRY, SARAH ABDOALATIF | 23d overdue |
| 18278904 | COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA | PIHONAK, SARAH | 22d |
| 18237360 | METALLOENZYME MODULATORS | PIHONAK, SARAH | 27d |
| 18687387 | PREPARATION METHOD FOR VENEER MANUFACTURED BOARD | PATWARDHAN, ABHISHEK A | 28d |
| 18277444 | ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF | FRONDA, CHRISTIAN L | 70d |
| 18518267 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | HOWELL, THEODORE R | 71d |
| Art Unit | Apps |
|---|---|
| 1693 | 4 |
| 1663 | 3 |
| 1635 | 2 |
| 1627 | 2 |
| 1642 | 2 |
| 1759 | 2 |
| 1658 | 2 |
| 1625 | 2 |
| 1731 | 2 |
| 1636 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19314941 | A METHOD FOR PRODUCING PLANTS WITH MINIMIZED BIOMASS BYPRODUCT AND ASSOCIATED PLANTS THEREOF | The Regents of the University of California | MCWILLIAMS, KELSEY LYNN | 1663 | §103 | Final Rejection | 26d | Pending | Aug 29, 2025 |
| 18883520 | TARGETED COMPOSITIONS | Arbutus Biopharma Corporation | OLSON, ANDREA STEFFEL | 1693 | §103 | Non-Final OA | 60d overdue | Pending | Sep 12, 2024 |
| 18634406 | SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF | The Regents of the University of California | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Non-Final OA | 131d overdue | Pending | Apr 12, 2024 |
| 18687387 | PREPARATION METHOD FOR VENEER MANUFACTURED BOARD | Wanhua Chemical Group Co., Ltd. | PATWARDHAN, ABHISHEK A | 1746 | §112 | Non-Final OA | 28d | Pending | Feb 28, 2024 |
| 18518267 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | Ardelyx, Inc. | HOWELL, THEODORE R | 1628 | DPOther | Final Rejection | 71d | Pending | Nov 22, 2023 |
| 18550500 | ANTIVIRAL PRODRUGS OF ETV AND FORMULATIONS THEREOF | The Scripps Research Institute | DEKARSKE, MADELINE MCGUIRE | 1622 | §103 | Non-Final OA | 33d | Pending | Sep 14, 2023 |
| 18462235 | METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS | Okava Pharmaceuticals, Inc. | YOUNG, MICAH PAUL | 1618 | §103 | Non-Final OA | 71d overdue | Pending | Sep 06, 2023 |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | UNIVERSITY OF IOWA RESEARCH FOUNDATION | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103 | Non-Final OA | 23d overdue | Pending | Aug 29, 2023 |
| 18278904 | COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA | Regents of the University of Michigan | PIHONAK, SARAH | 1627 | §103 | Non-Final OA | 22d | Pending | Aug 25, 2023 |
| 18237360 | METALLOENZYME MODULATORS | Regents Of The University Of Minnesota | PIHONAK, SARAH | 1627 | §102 | Non-Final OA | 27d | Pending | Aug 23, 2023 |
| 18277444 | ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | FRONDA, CHRISTIAN L | 1652 | §103 | Non-Final OA | 70d | Pending | Aug 16, 2023 |
| 18276823 | ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF | Denali Therapeutics Inc. | LU, CHENG | 1642 | Other | Non-Final OA | 46d | Pending | Aug 10, 2023 |
| 18264890 | IMMUNE REGULATORS INVOLVED IN DEFENSE AGAINST PLANT DISEASES CAUSED BY LIBERIBACTER SPECIES | The Regents of the University of California | WILLIAMS, KEITH RICHARD | 1663 | §112 | Final Rejection | 56d | Pending | Aug 09, 2023 |
| 18274863 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | 35d overdue | Pending | Jul 28, 2023 |
| 18274907 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | BEKKER, KELLY JO | 1792 | §103 | Final Rejection | 84d | Pending | Jul 28, 2023 |
| 18274649 | Surface Modified Red Blood Cells And Methods Of Generating The Same | City University Of Hong Kong | KELLY, ROBERT M | 1638 | §102 | Non-Final OA | 85d overdue | Pending | Jul 27, 2023 |
| 18274412 | INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | BANERJEE, KOYELI | 1658 | §103 | Non-Final OA | 13d | Pending | Jul 26, 2023 |
| 18332851 | PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS | The Scripps Research Institute | ENGLISH, CONNOR KENNEDY | 1625 | §102 | Non-Final OA | 26d | Pending | Jun 12, 2023 |
| 18256680 | A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN | The Scripps Research Institute | SEAMAN, D MARGARET M | 1625 | §103 | Final Rejection | 60d overdue | Pending | Jun 09, 2023 |
| 18141728 | MASKED SINGLE-DOMAIN ANTIBODIES AND METHODS THEREOF | Regents Of The University Of Minnesota | TAYLOR, LIA ELAN | 1641 | §103 | Non-Final OA | 19d | Pending | May 01, 2023 |
| 18034603 | DESIGN METHODS AND MOTION CONTROL ALGORITHMS FOR IMPACT-RESILIENT MOBILE ROBOTS | The Regents of the University of California | MUELLER, SARAH ALEXANDRA | 3669 | §103 | Non-Final OA | 53d overdue | Pending | Apr 28, 2023 |
| 18247616 | A DNA Assembly Mix And Method Of Uses Thereof | National University Of Singapore | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | 9d overdue | Pending | Mar 31, 2023 |
| 18024034 | DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD | UNIVERSITY OF IOWA RESEARCH FOUNDATION | PAK, JOHN D | 1699 | §102 | Final Rejection | 53d | Pending | Feb 28, 2023 |
| 18110292 | METHOD FOR PREPARING ACTIVATED CARBON | The Regents of the University of California | MENON, KRISHNAN S | 1777 | §103 | Final Rejection | 191d overdue | Pending | Feb 15, 2023 |
| 18017541 | PYRAZOLOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | DAHLIN, HEATHER RAQUEL | 1629 | Other | Non-Final OA | 2d overdue | Pending | Jan 23, 2023 |
| 18085880 | MECHANOCHEMICAL OXIDATION METHOD | UNIVERSITY OF IOWA RESEARCH FOUNDATION | FIORITO, JAMES A | 1731 | §112 | Final Rejection | 12d | Pending | Dec 21, 2022 |
| 18010108 | BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER | Minomic International Ltd. | POHNERT, STEVEN C | 1683 | DPOther | Non-Final OA | 77d | Pending | Dec 13, 2022 |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | WANG, RUIXUE | 1672 | §102 | Non-Final OA | 20d | Pending | Dec 05, 2022 |
| 17928535 | METHOD FOR PROVIDING CORROSION PROTECTION TO A PRESSURIZED WATER-STEAM SYSTEM | Kurita Water Industries Ltd. | DIAZ, MATTHEW R | 1761 | §103 | Non-Final OA | 51d overdue | Pending | Nov 29, 2022 |
| 18071353 | THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B | Arbutus Biopharma Corporation | WHITEMAN, BRIAN A | 1636 | §102 | Final Rejection | 43d overdue | Pending | Nov 29, 2022 |
| 18070288 | CHLOROPLAST TARGETING PEPTIDES AND CONJUGATES AND COMPOSITIONS THEREOF | The Regents of the University of California | SPEED, DEQUANTARIUS JAVON | 1663 | §103 | Non-Final OA | 15d | Pending | Nov 28, 2022 |
| 17923171 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2 | The Scripps Research Institute | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Non-Final OA | 65d | Pending | Nov 03, 2022 |
| 17920231 | EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF | Research Institute AT Nationwide Children'S Hospital | BOWLES, DAVID PAUL | 1654 | §112 | Non-Final OA | 28d | Pending | Oct 20, 2022 |
| 17918448 | GUANIDINE-MODIFIED C-TERMINUS VANCOMYCIN COMPOUNDS, COMPOSITIONS AND METHODS | The Scripps Research Institute | REYNOLDS, FRED H | 1658 | Other | Non-Final OA | 30d overdue | Pending | Oct 12, 2022 |
| 17800806 | ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE | European Molecular Biology Laboratory | MEYERING, SHABANA SHABBEER | 1635 | §103 | Non-Final OA | 5d overdue | Pending | Aug 18, 2022 |
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | Denali Therapeutics Inc. | CHANDRA, GYAN | 1674 | Other | Non-Final OA | 37d overdue | Pending | Aug 04, 2022 |
| 17794527 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | Point Loma Nazarene University | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §102 | Non-Final OA | 27d | Pending | Jul 21, 2022 |
| 17787089 | SYNTHETIC PROCESSES AND INTERMEDIATES | Arbutus Biopharma Corporation | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Non-Final OA | 21d | Pending | Jun 17, 2022 |
| 17784879 | ABS RUBBER POWDER WITH LOW IMPURITY CONTENT, PREPARATION METHOD THEREFOR, AND ABS RESIN | Wanhua Chemical Group Co., Ltd. | BLAND, ALICIA | 1759 | §103 | Final Rejection | 19d | Pending | Jun 13, 2022 |
| 17640215 | DUST BINDING AGENT FOR FERTILIZER | K+S Aktiengesellschaft | SMITH, JENNIFER A | 1731 | §103 | Non-Final OA | 124d overdue | Pending | Mar 03, 2022 |
| 17631209 | PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | Lexicon Pharmaceuticals, Inc. | BERRY, LAYLA D | 1693 | Other | Final Rejection | 53d | Pending | Jan 28, 2022 |
| 17625020 | POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY | Regents Of The University Of Minnesota | LEE, HOI YAN NMN | 1693 | §103 | Non-Final OA | 23d overdue | Pending | Jan 05, 2022 |
| 17533991 | HYDROGEL-BASED 3D CELL TRAINING BIOREACTOR | The Chinese University of Hong Kong | HURST, JONATHAN M | 1799 | §103 | Non-Final OA | 8d overdue | Pending | Nov 23, 2021 |
| 17507752 | CASCADED TYPE II SUPERLATTICE INFRARED DETECTOR OPERATING AT 300 K | Firefly Photonics, LLC | BAUMAN, SCOTT E | 2815 | §103 | Non-Final OA | 73d overdue | Pending | Oct 21, 2021 |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | Denali Therapeutics Inc. | AEDER, SEAN E | 1642 | §103 | Non-Final OA | 15d overdue | Pending | May 24, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial